Effects of nifedipine on myocardial blood flow and systolic function in humans with ischemic heart disease

Coronary Artery Disease

Volumn 10, Issue 3, 1999, Pages 185-194

  Zervos, Gerasimos ^a   Zusman, Randall M ^a   Swindle, Leslie A ^a   Alpert, Nathaniel M ^a   Fischman, Alan J ^a   Gewirtz, Henry ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ischemic heart disease; Myocardial blood flow; Nifedipine

Indexed keywords

CORONARY VASODILATING AGENT; NIFEDIPINE;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; MALE; ORAL DRUG ADMINISTRATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; SYSTOLE;

EID: 0033061012     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199905000-00008     Document Type: Article

References (34)

1. 1 Heusch G, Guth BD, Seitelberger R Jr. Attenuation of exercise induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine. Circulation 1987; 75:482-490.
2. 2 Stoddard MF, Wagner SG, Ikram S, Longaker RA, Prince CR. Effects of nifedipine and nitroglycerin on left ventricular systolic dysfunction and impaired diastolic filling after exercise-induced ischemia in humans. J Am Coll Cardiol 1996; 28:915-923.
3. 3 Lorell BH, Turi Z, Grossman W. Modification of left ventricular response to pacing tachycardia by nifedipine in patients with coronary artery disease. Am J Med 1981; 71:667-675.
4. 4 Rice KR, Gervino E, Jarisch WR, Stone PH. Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris. Am J Cardiol 1990; 65:1097-1101.
5. 5 Furberg CD, Psaty BM, Meyer JV. Nifedipine: dose related increase in mortality in patients with coronary heart disease. Circulation 1995; 92:1326-1331.
6. 6 Kloner RA. Nifedipine in ischemic heart disease [editorial]. Circulation 1995; 95:1074-1078.
7. 7 Yusuf S. Calcium antagonists in coronary artery disease and hypertension: Time for reevaluation [editorial]. Circulation 1995; 92:1079-1082.
8. 8 Opie LH, Messerli FH. Nifedipine and mortality: grave defects in the dossier [editorial]. Circulation 1995; 92:1068-1073.
9. 9 Gewirtz H, Gross SL, Williams DO, Most AS. Contrasting effects of nifedipine and adenosine on regional flow distribution and metabolism distal to a severe coronary arterial stenosis: observations in sedated, closed-chest domestic swine. Circulation 1984; 69:1048-1057.
10. 10 Gewirtz H, Fischman AJ, Abraham SA, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permit identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994; 23:851-859.
11. 11 Gewirtz H, Skopicki HA, Abraham SA, Castano H, Dinsmore RE, Alpert NA, et al. Quantitative PET measurements of regional myocardial blood flow: observations in humans with ischemic heart disease. Cardiology 1997; 88:62-70.
12. 12 Skopicki H, Abraham S, Picard M, Alpert N, Fischman A, Gewirtz H. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation 1997; 96:3346-3352.
13. 13 Skopicki HA, Abraham SA, Weissman NJ, Mukerjee AK, Alpert NA, Fischman AJ, et al. Factors influencing regional myocardial contractile response to inotropic stimulation: analysis in humans with stable ischemic heart disease. Circulation 1996; 94:643-650.
14. 14 Van Harten J, Burggraaf K, Danhof M, Van Brummelen P, Breimer DD. Negligible sublingual absorption of nifedipine. Lancet 1987; 11:1363-1365.
15. 15 Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert HR, Kuhl D. Noninvasive quantification of regional myocardial blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990; 15:1032-1042.
16. 16 Krivokapich J, Smith GT, Huang SC, Hoffman EJ, Ratib O, Phelps ME, et al. 13-N ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989; 80:1328-1337.
17. 17 Callahan RJ, Froelich JW, McKusick KA, Leppo J, Strauss HW. A modified method for the in vivo labeling of red blood cells with Tc-99m [concise communication]. J Nucl Med 1982; 23:315-318.
18. 18 Iskandrian AS, Hakki A, Bemis CE, Kane SA, Boston B, Amenta A. Left ventricular end-systolic pressure-volume relation. A combined radionuclide and hemodynamic study. Am J Cardiol 1983; 51:1057-1061.
19. 19 Sambuceti G, Marzullo P, Giorgetti A, Neglia D, Marzilli M, Salvadori P, et al. Global alteration in perfusion response to increasing oxygen consumption in patients with single vessel coronary artery disease. Circulation 1994; 90:1696-1705.
20. 20 Vatner S. Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res 1980; 47:201-207.
21. 21 Gallagher KP, Matsuzaki M. Osakada G, Kemper WS, Ross JR Jr. Effect of exercise on the relationship between myocardial blood flow and systolic wall thickening in dogs with acute coronary stenosis. Circ Res 1983; 52:716-729.
22. 22 Geary GG, Smith GT, Suehiro GT, McNamara JJ. Failure of nifedipine therapy to reduce myocardial infarct size in the baboon. Am J Cardiol 1982; 49:331-338.
23. 23 Henry PD, Shuchleib R, Borda LJ, Roberts R, Williamson JR, Sobel BE. Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res 1978; 43:372-380.
24. 24 Henry PD, Schuchleib R, Clark RE, Perez JE. Effect of nifedipine on myocardial ischemia: analysis of collateral flow, pulsatile beat and regional muscle shortening. Am J Cardiol 1979; 44:817-824.
25. 25 Selwyn AR Welman E, Fox K, Horlock P, Pratt T, Klein M. The effects of nifedipine on acute experimental myocardial ischemia and infarction in dogs. Circ Res 1979; 44:16-23.
26. 26 Weintraub WS, Hattori S, Agarwal JB, Bodenheimer MM, Banka VS, Helfant RH. Effects of nifedipine on myocardial blood flow and contraction during ischemia in the dog. Circulation 1982; 65:49-53.
27. 27 Stone DL, Stephens JD, Banim SO. Coronary haemodynamic effects of nifedipine: comparison with glyceryl trinitrate. Br Heart J 1983; 49:442-446.
28. 28 Engel HJ, Lichtlen PR. Beneficial enhancement of coronary blood flow by nifedipine: comparison with nitroglycerin and beta blocking agents. Am J Med 1981; 71:658-666.
29. 29 Schanzenbacher P, Gottfert G, Liebau G, Kochsiek K. Coronary hemodynamic and metabolic effects of nifedipine in patients with coronary artery disease treated with beta-blocking drugs. Am J Cardiol 1985; 55:33-36.
30. 30 Gerstenblith G, Ouyang P, Achuff SC, Buckley BH, Becker LC, Mellitis ED, et al. Nifedipine in unstable angina: a double blind, randomized trial. N Engl J Med 1982; 306:885-889.
31. 31 Muller JE, Morrison J, Stone PH, Rude RE, Rosner B, Roberts R, et al. Nifedipine therapy for patients with threatened and acute myocardial infraction: a randomized, double-blind, placebo-controlled comparison. Circulation 1984; 69:740-747.
32. 32 Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease [review]. Circulation 1995; 92:2333-2342.
33. 33 Berman M, Fischman AJ, Southern J, Carter E, Mirecki F, Strauss HW, et al. Myocardial adaptation during and after sustained demand-induced ischemia: observations in closed-chest domestic swine. Circulation 1996; 94:755-762.
34. 34 Kennedy JW, Baxley WA, Figley MM, Dodge HT, Blackmon JR. Quantitative angiocardiography: I. The normal left ventricle of man. Circulation 1966; 34:272-278.